Bausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) P/S ratio
As of 5 November 2026, Bausch + Lomb Corporation (BLCO) trades at a P/S ratio of 1.3×. Over the past ten years it has ranged from 0.8× (May 2025) to 1.9× (July 2023); the current reading is higher than 53% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.2× | (10.66%) |
| FY2024 | 1.3× | (7.29%) |
| FY2023 | 1.4× | (2.04%) |
| FY2022 | 1.5× | (21.30%) |
| FY2021 | 1.9× | 0.00% |
| FY2020 | 1.9× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 1.1× | 1.02% |
| Jun 2026 | 1.1× | 2.43% |
| Mar 2026 | 1.1× | (8.47%) |
| Dec 2025 | 1.2× | 10.44% |
| 19 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BLCO Bausch + Lomb Corporation | 1.3× |
| AVTR Avantor, Inc. compare | 1.5× |
| MMED MiniMed Group, Inc. compare | 1.7× |
| ATR AptarGroup, Inc. compare | 2.3× |
| ALGN Align Technology, Inc. compare | 2.7× |
| COO The Cooper Companies, Inc. compare | 2.9× |
| TFX Teleflex Incorporated compare | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.3× |
| RGEN Repligen Corporation compare | 11.9× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement